Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

IMPORTANCE: Current treatment cures most cases of early-stage, primary breast cancer. However, better techniques are required to identify which patients are at risk of relapse. OBJECTIVE: To assess the clinical validity of molecular relapse detection with circulating tumor DNA (ctDNA) analysis in ea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Oncol
Glavni autori: Garcia-Murillas, Isaac, Chopra, Neha, Comino-Méndez, Iñaki, Beaney, Matthew, Tovey, Holly, Cutts, Rosalind J., Swift, Claire, Kriplani, Divya, Afentakis, Maria, Hrebien, Sarah, Walsh-Crestani, Giselle, Barry, Peter, Johnston, Stephen R. D., Ring, Alistair, Bliss, Judith, Russell, Simon, Evans, Abigail, Skene, Anthony, Wheatley, Duncan, Dowsett, Mitch, Smith, Ian E., Turner, Nicholas C.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Brief Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681568/
https://ncbi.nlm.nih.gov/pubmed/31369045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.1838
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items